White Papers

1. Five Ways Centralized Trial Finance Improves Site And Patient Satisfaction 6/15/2026

   Centralizing payments and logistics improves transparency, accelerates reimbursements, and supports better site performance and patient retention in clinical trials.

2. 2026 Annual Completed Clinical Trials Report: Strong Headwinds And Winds Of Change 6/11/2026

   Are your Phase I–III/IV clinical studies prepared for today's regulatory landscape? Learn how leading organizations are addressing compliance, transparency, and data ownership risks.

3. How Remote Pharmacy Monitoring Improves Trial Compliance 6/10/2026

   Explore how leading IDS pharmacies are using remote monitoring workflows and digital accountability systems to improve accuracy, reduce site burden, and maintain audit readiness.

4. Demonstrating IDS Value With Time-Based Metrics 6/10/2026

   Explore how leading IDS pharmacies are using remote monitoring workflows and digital accountability systems to improve accuracy, reduce site burden, and maintain audit readiness.

5. Meeting The FDA's New Real-World Evidence Standards 5/27/2026

   FDA guidance is reshaping RWE strategy. Sponsors that build interoperable, audit-ready RWD infrastructure now will be best positioned for faster, defensible submissions.

6. The eCOA Iceberg 5/27/2026

   Understand the true cost of eCOA deployment, beyond software licenses, to reduce protocol risk, avoid operational bottlenecks, and protect study timelines and data quality.

7. Navigating The Challenges Of Large, International Phase III Breast Cancer Trials 5/27/2026

   In the competitive landscape of breast cancer research, aligning biomarker testing, regulatory pathways, and regional operations from day one creates a path to faster enrollment and stronger outcomes.

8. De-Risking The Neurology IND: Lessons From Early FDA Engagement 5/27/2026

   Learn how early FDA alignment can help your neurology program move forward with greater clarity, confidence, and regulatory readiness.

9. Faster Starts, Stronger Finish: Operational Excellence In NSCLC 5/22/2026

   In NSCLC trials, data‑driven site selection, streamlined protocols, efficient screening strategies, and proactive engagement can accelerate enrollment and improve trial efficiency across regions.

10. How Adaptive Design Accelerates Early‑Phase NSCLC Development 5/22/2026

    Adaptive trial designs and an adaptive mindset enable non-small cell lung cancer (NSCLC) sponsors to optimize dose, respond to evolving expectations, and accelerate early‑phase development.